POMT1 and POMT2 mutations in CMD patients

A multicentric Italian study

S. Messina, M. Mora, E. Pegoraro, A. Pini, T. Mongini, A. D'Amico, M. Pane, C. Aiello, C. Bruno, R. Biancheri, A. Berardinelli, C. Boito, L. Farina, L. Morandi, I. Moroni, R. Pezzani, A. Pichiecchio, E. Ricci, A. Ruggieri, S. Saredi & 9 others C. Scuderi, A. Tessa, A. Toscano, G. Tortorella, C. P. Trevisan, C. Uggetti, F. M. Santorelli, E. Bertini, E. Mercuri

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Mutations in POMT1 and POMT2 genes were originally identified in Walker-Warburg syndrome (WWS) and subsequently reported in patients with milder phenotypes characterised by mental retardation with or without brain abnormalities and without ocular malformations. As part of a multicentric Italian study we screened the POMT1 and POMT2 genes in 61 congenital muscular dystrophy (CMD) patients with α-dystroglycan reduction on muscle biopsy and/or clinical and radiological findings suggestive of the known forms of CMD with α-dystroglycan deficiency. The aim of the study was to establish how frequently mutations in POMT1 and POMT2 occur in CMD patients in the Italian population and to evaluate the spectrum of associated phenotypes. Thirteen patients showed mutations in POMT1 and five harboured mutations in POMT2, accounting for a total of 20 different mutations, eight of which were novel (two in POMT1 and six in POMT2). Normal brain MRI associated with mental retardation and microcephaly was the most frequent finding in patients with mutations in POMT1 (six out of 13), but was also found in a patient with POMT2 mutations. Predominant cerebellar hypoplasia was also frequent both in patients with POMT1 (three out of 13) and POMT2 (three out of 5) mutations. A MEB phenotype with frontal cortical dysplasia and pons abnormalities was found in two patients with POMT1 and in one with POMT2 mutations, while a WWS phenotype was only found in a case with mutations in POMT1. Mutations causing frameshifts and stop codons were responsible for the more severe phenotypes. Our results provide further evidence that, as previously reported for FKRP, the array of mutations in POMT1 and POMT2 is ample and the spectrum of associated phenotypes is wider than initially thought.

Original languageEnglish
Pages (from-to)565-571
Number of pages7
JournalNeuromuscular Disorders
Volume18
Issue number7
DOIs
Publication statusPublished - Jul 2008

Fingerprint

Muscular Dystrophies
Mutation
Phenotype
Walker-Warburg Syndrome
Dystroglycans
Intellectual Disability
Malformations of Cortical Development
Microcephaly
Frameshift Mutation
Pons
Terminator Codon
Brain
Genes
Biopsy

Keywords

  • Alpha-dystroglycanopathy
  • Congenital muscular dystrophy
  • Mental retardation
  • POMT1
  • POMT2

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Developmental Neuroscience
  • Neurology

Cite this

POMT1 and POMT2 mutations in CMD patients : A multicentric Italian study. / Messina, S.; Mora, M.; Pegoraro, E.; Pini, A.; Mongini, T.; D'Amico, A.; Pane, M.; Aiello, C.; Bruno, C.; Biancheri, R.; Berardinelli, A.; Boito, C.; Farina, L.; Morandi, L.; Moroni, I.; Pezzani, R.; Pichiecchio, A.; Ricci, E.; Ruggieri, A.; Saredi, S.; Scuderi, C.; Tessa, A.; Toscano, A.; Tortorella, G.; Trevisan, C. P.; Uggetti, C.; Santorelli, F. M.; Bertini, E.; Mercuri, E.

In: Neuromuscular Disorders, Vol. 18, No. 7, 07.2008, p. 565-571.

Research output: Contribution to journalArticle

Messina, S, Mora, M, Pegoraro, E, Pini, A, Mongini, T, D'Amico, A, Pane, M, Aiello, C, Bruno, C, Biancheri, R, Berardinelli, A, Boito, C, Farina, L, Morandi, L, Moroni, I, Pezzani, R, Pichiecchio, A, Ricci, E, Ruggieri, A, Saredi, S, Scuderi, C, Tessa, A, Toscano, A, Tortorella, G, Trevisan, CP, Uggetti, C, Santorelli, FM, Bertini, E & Mercuri, E 2008, 'POMT1 and POMT2 mutations in CMD patients: A multicentric Italian study', Neuromuscular Disorders, vol. 18, no. 7, pp. 565-571. https://doi.org/10.1016/j.nmd.2008.04.004
Messina, S. ; Mora, M. ; Pegoraro, E. ; Pini, A. ; Mongini, T. ; D'Amico, A. ; Pane, M. ; Aiello, C. ; Bruno, C. ; Biancheri, R. ; Berardinelli, A. ; Boito, C. ; Farina, L. ; Morandi, L. ; Moroni, I. ; Pezzani, R. ; Pichiecchio, A. ; Ricci, E. ; Ruggieri, A. ; Saredi, S. ; Scuderi, C. ; Tessa, A. ; Toscano, A. ; Tortorella, G. ; Trevisan, C. P. ; Uggetti, C. ; Santorelli, F. M. ; Bertini, E. ; Mercuri, E. / POMT1 and POMT2 mutations in CMD patients : A multicentric Italian study. In: Neuromuscular Disorders. 2008 ; Vol. 18, No. 7. pp. 565-571.
@article{3b8e8e3d5a63477ca587c9c573772d5d,
title = "POMT1 and POMT2 mutations in CMD patients: A multicentric Italian study",
abstract = "Mutations in POMT1 and POMT2 genes were originally identified in Walker-Warburg syndrome (WWS) and subsequently reported in patients with milder phenotypes characterised by mental retardation with or without brain abnormalities and without ocular malformations. As part of a multicentric Italian study we screened the POMT1 and POMT2 genes in 61 congenital muscular dystrophy (CMD) patients with α-dystroglycan reduction on muscle biopsy and/or clinical and radiological findings suggestive of the known forms of CMD with α-dystroglycan deficiency. The aim of the study was to establish how frequently mutations in POMT1 and POMT2 occur in CMD patients in the Italian population and to evaluate the spectrum of associated phenotypes. Thirteen patients showed mutations in POMT1 and five harboured mutations in POMT2, accounting for a total of 20 different mutations, eight of which were novel (two in POMT1 and six in POMT2). Normal brain MRI associated with mental retardation and microcephaly was the most frequent finding in patients with mutations in POMT1 (six out of 13), but was also found in a patient with POMT2 mutations. Predominant cerebellar hypoplasia was also frequent both in patients with POMT1 (three out of 13) and POMT2 (three out of 5) mutations. A MEB phenotype with frontal cortical dysplasia and pons abnormalities was found in two patients with POMT1 and in one with POMT2 mutations, while a WWS phenotype was only found in a case with mutations in POMT1. Mutations causing frameshifts and stop codons were responsible for the more severe phenotypes. Our results provide further evidence that, as previously reported for FKRP, the array of mutations in POMT1 and POMT2 is ample and the spectrum of associated phenotypes is wider than initially thought.",
keywords = "Alpha-dystroglycanopathy, Congenital muscular dystrophy, Mental retardation, POMT1, POMT2",
author = "S. Messina and M. Mora and E. Pegoraro and A. Pini and T. Mongini and A. D'Amico and M. Pane and C. Aiello and C. Bruno and R. Biancheri and A. Berardinelli and C. Boito and L. Farina and L. Morandi and I. Moroni and R. Pezzani and A. Pichiecchio and E. Ricci and A. Ruggieri and S. Saredi and C. Scuderi and A. Tessa and A. Toscano and G. Tortorella and Trevisan, {C. P.} and C. Uggetti and Santorelli, {F. M.} and E. Bertini and E. Mercuri",
year = "2008",
month = "7",
doi = "10.1016/j.nmd.2008.04.004",
language = "English",
volume = "18",
pages = "565--571",
journal = "Neuromuscular Disorders",
issn = "0960-8966",
publisher = "Elsevier Ltd",
number = "7",

}

TY - JOUR

T1 - POMT1 and POMT2 mutations in CMD patients

T2 - A multicentric Italian study

AU - Messina, S.

AU - Mora, M.

AU - Pegoraro, E.

AU - Pini, A.

AU - Mongini, T.

AU - D'Amico, A.

AU - Pane, M.

AU - Aiello, C.

AU - Bruno, C.

AU - Biancheri, R.

AU - Berardinelli, A.

AU - Boito, C.

AU - Farina, L.

AU - Morandi, L.

AU - Moroni, I.

AU - Pezzani, R.

AU - Pichiecchio, A.

AU - Ricci, E.

AU - Ruggieri, A.

AU - Saredi, S.

AU - Scuderi, C.

AU - Tessa, A.

AU - Toscano, A.

AU - Tortorella, G.

AU - Trevisan, C. P.

AU - Uggetti, C.

AU - Santorelli, F. M.

AU - Bertini, E.

AU - Mercuri, E.

PY - 2008/7

Y1 - 2008/7

N2 - Mutations in POMT1 and POMT2 genes were originally identified in Walker-Warburg syndrome (WWS) and subsequently reported in patients with milder phenotypes characterised by mental retardation with or without brain abnormalities and without ocular malformations. As part of a multicentric Italian study we screened the POMT1 and POMT2 genes in 61 congenital muscular dystrophy (CMD) patients with α-dystroglycan reduction on muscle biopsy and/or clinical and radiological findings suggestive of the known forms of CMD with α-dystroglycan deficiency. The aim of the study was to establish how frequently mutations in POMT1 and POMT2 occur in CMD patients in the Italian population and to evaluate the spectrum of associated phenotypes. Thirteen patients showed mutations in POMT1 and five harboured mutations in POMT2, accounting for a total of 20 different mutations, eight of which were novel (two in POMT1 and six in POMT2). Normal brain MRI associated with mental retardation and microcephaly was the most frequent finding in patients with mutations in POMT1 (six out of 13), but was also found in a patient with POMT2 mutations. Predominant cerebellar hypoplasia was also frequent both in patients with POMT1 (three out of 13) and POMT2 (three out of 5) mutations. A MEB phenotype with frontal cortical dysplasia and pons abnormalities was found in two patients with POMT1 and in one with POMT2 mutations, while a WWS phenotype was only found in a case with mutations in POMT1. Mutations causing frameshifts and stop codons were responsible for the more severe phenotypes. Our results provide further evidence that, as previously reported for FKRP, the array of mutations in POMT1 and POMT2 is ample and the spectrum of associated phenotypes is wider than initially thought.

AB - Mutations in POMT1 and POMT2 genes were originally identified in Walker-Warburg syndrome (WWS) and subsequently reported in patients with milder phenotypes characterised by mental retardation with or without brain abnormalities and without ocular malformations. As part of a multicentric Italian study we screened the POMT1 and POMT2 genes in 61 congenital muscular dystrophy (CMD) patients with α-dystroglycan reduction on muscle biopsy and/or clinical and radiological findings suggestive of the known forms of CMD with α-dystroglycan deficiency. The aim of the study was to establish how frequently mutations in POMT1 and POMT2 occur in CMD patients in the Italian population and to evaluate the spectrum of associated phenotypes. Thirteen patients showed mutations in POMT1 and five harboured mutations in POMT2, accounting for a total of 20 different mutations, eight of which were novel (two in POMT1 and six in POMT2). Normal brain MRI associated with mental retardation and microcephaly was the most frequent finding in patients with mutations in POMT1 (six out of 13), but was also found in a patient with POMT2 mutations. Predominant cerebellar hypoplasia was also frequent both in patients with POMT1 (three out of 13) and POMT2 (three out of 5) mutations. A MEB phenotype with frontal cortical dysplasia and pons abnormalities was found in two patients with POMT1 and in one with POMT2 mutations, while a WWS phenotype was only found in a case with mutations in POMT1. Mutations causing frameshifts and stop codons were responsible for the more severe phenotypes. Our results provide further evidence that, as previously reported for FKRP, the array of mutations in POMT1 and POMT2 is ample and the spectrum of associated phenotypes is wider than initially thought.

KW - Alpha-dystroglycanopathy

KW - Congenital muscular dystrophy

KW - Mental retardation

KW - POMT1

KW - POMT2

UR - http://www.scopus.com/inward/record.url?scp=46449124425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46449124425&partnerID=8YFLogxK

U2 - 10.1016/j.nmd.2008.04.004

DO - 10.1016/j.nmd.2008.04.004

M3 - Article

VL - 18

SP - 565

EP - 571

JO - Neuromuscular Disorders

JF - Neuromuscular Disorders

SN - 0960-8966

IS - 7

ER -